BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31948534)

  • 1. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
    Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
    Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
    Lou M; Gao Z; Zhu T; Mao X; Wang Y; Yuan K; Tong J
    Oncol Lett; 2020 Feb; 19(2):1400-1408. PubMed ID: 31966070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
    He R; Liu H
    Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of RIN1 gene expression in human non-small cell lung cancer.
    Wang Q; Gao Y; Tang Y; Ma L; Zhao M; Wang X
    Acta Histochem; 2012 Sep; 114(5):463-8. PubMed ID: 21925717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An TRIM59-CDK6 axis regulates growth and metastasis of lung cancer.
    Geng B; Liang M; Qin L; Zhao W; Wang H; Wang L; Pan X; Chen X
    J Cell Mol Med; 2019 Feb; 23(2):1458-1469. PubMed ID: 30515965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-30 Play an Important Role in Non-Small Cell Lung Cancer (NSCLC).
    Sui JYAX
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
    Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
    Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis.
    Guo J; Min K; Deng L
    Medicine (Baltimore); 2021 Aug; 100(32):e26868. PubMed ID: 34397900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM66 expression in non-small cell lung cancer: A new predictor of prognosis.
    Ma Y; Dai HY; Zhang F; Zhao D
    Cancer Biomark; 2017 Sep; 20(3):309-315. PubMed ID: 28946563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM59: A potential diagnostic and prognostic biomarker in human tumors.
    Jin Z; Liu L; Yu Y; Li D; Zhu X; Yan D; Zhu Z
    PLoS One; 2021; 16(9):e0257445. PubMed ID: 34534244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.
    Hao L; Du B; Xi X
    Oncol Lett; 2017 Aug; 14(2):2153-2164. PubMed ID: 28789440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
    Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
    Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level.
    Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S
    Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of FATS in non-small cell lung cancer and its relationship with prognosis].
    Zhang TM; Zhang J; Zhou DJ; Wang CL
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):826-830. PubMed ID: 31770849
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
    Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
    Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma.
    Wu L; Yin X; Jiang K; Yin J; Yu H; Yang L; Ma C; Yan S
    Cancer Med; 2022 Apr; 11(7):1712-1731. PubMed ID: 35142083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of Snail and Claudin-3 in non-small cell lung cancer].
    Li J; Tu Y; Jiang L; Xu H; Zhang S
    Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):583-90. PubMed ID: 23075682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.